MissionIR Articles
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Beginning of MS1819 Extension Study with Initial Dosing of Two Patients
AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, has begun its Phase 2b OPTION 2 extension study of MS1819. AZRX announced that the first…
-
AB International Group Corp. (ABQQ) Leading the Way in Cryptocurrency Education and Access
Acquired a cryptocurrency kiosk company, KryptoKiosk Ltd. Working to make cryptocurrency easier to understand and more accessible for everyone Creating an internationally recognizable brand with individual investors AB International Group Corp. (OTCQB: ABQQ), a company…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Builds Major Solana Treasury with Nearly 7M SOL
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Processing Strategy amid Rising Rare Earth Prices
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Secures Authorization for Core Product Placement Across 1,000 U.S. Retail Locations
- Soligenix Inc. (NASDAQ: SNGX) Leverages Platform Science for Broader Therapeutic Reach
- MissionIRNewsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Identifies Amp Z as Stealth Hyperscale AI Data Center Partner